Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer

Steven M. Strasberg, Farrokh Dehdashti

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

Staging by FDG-PET of patients who are candidates for surgical treatment of colorectal metastases is an essential part of management of this problem. FDG-PET is highly sensitive and specific for intrahepatic colorectal tumors and the most sensitive test for extrahepatic tumors. FDG-PET alters management in 25% of patients, reducing futile laparotomies and hepatectomies. © 2010 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)955-959
Number of pages5
JournalJournal of surgical oncology
Volume102
Issue number8
DOIs
StatePublished - Dec 15 2010

Keywords

  • colorectal metastases
  • heaptic metastases
  • surgical resection

Fingerprint

Dive into the research topics of 'Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer'. Together they form a unique fingerprint.

Cite this